HomeBusinessHealthcareAllovir (ALVR) Stock Up On RMAT Designation
Allovir (ALVR) Stock Up On RMAT Designation

Allovir (ALVR) is today’s Under 30-stock. In this segment Jenny Horne and Alex Coffey discuss Allovir (ALVR) which is a late clinical-stage allogeneic T cell immunotherapy company. Jenny and George Tsilis talk the announcement Wednesday that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to Allovir’s (ALVR) investigative T cell therapy posoleucel, a therapy designed to treat infections and diseases from six common viruses. An RMAT designation means a faster, more streamlined approval process. Alex and George talk about how the news resulted in Allovir’s (ALVR) biggest trading day ever yesterday.

ON AIR
2:00 pm
Market On Close
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
ON AIR
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US